Anticuerpos primarios

<p>Rabbit anti-chicken IgY (H + L) (FITC) was raised in rabbit using chicken IgG (H &amp; L) as the immunogen.</p>

<p>Hemoglobin A1c antibody was raised in sheep using human hemoglobin A1c as the immunogen.</p>

<p>The CXCL9 antibody is a highly specialized monoclonal antibody that targets the cryptosporidium parasite. It belongs to the class of adeno-associated antibodies and has been extensively studied in the field of Life Sciences. This antibody specifically binds to caspase-9, a target molecule involved in apoptosis. It has been shown to effectively inhibit the growth and replication of cryptosporidium in bioassays.</p>

<p>Cytokeratin 8 antibody (biotin) was raised in mouse using cytoskeletal proteins from cultured HeLa Cells as the immunogen.</p>

<p>Goat anti-cat IgG (H + L) (biotin) was raised in goat using feline IgG whole molecule as the immunogen.</p>

<p>Mouse monoclonal Insulin+Proinsulin antibody</p>

<p>The PSA antibody is a growth factor that belongs to the class of monoclonal antibodies. It has the ability to specifically bind to prostate-specific antigen (PSA) and inhibit its activity. This antibody can be used for various applications in the field of Life Sciences, including ultrasensitive detection of PSA levels in patient samples. The PSA antibody has been shown to induce lysis of PSA-expressing cells and neutralize its biological effects. It also has the ability to bind to collagen and fibronectin, which are important components of the extracellular matrix. In addition, this monoclonal antibody can be activated to exert cytotoxic effects on target cells. Its efficacy can be measured using techniques such as electrochemical impedance spectroscopy.</p>

<p>Legionella pneumophila (serogroup 1) antibody was raised in mouse using Legionella pneumophila antigenic subgroup knoxville 1 as the immunogen.</p>

<p>CKMM antibody was raised in goat using human skeletal muscle CK-MM isoenzyme as the immunogen.</p>

<p>Hemoglobin antibody was raised in mouse using human hemoglobin as the immunogen.</p>

<p>Rabbit polyclonal TUBA8 antibody</p>

<p>Plasmodium falciparum antibody was raised in mouse using histadine rich protein II from Plasmodium falciparum as the immunogen.</p>

<p>Myoglobin antibody was raised in mouse using human cardiac myoglobin as the immunogen.</p>

<p>PSA antibody was raised in mouse using human seminal fluid PSA as the immunogen.</p>

<p>The HBsAg antibody is a low-density monoclonal antibody that is used in Life Sciences for various applications. This antibody specifically targets and binds to the hepatitis B surface antigen (HBsAg), which is a key marker of hepatitis B infection. By binding to HBsAg, this antibody can be used in assays to detect and quantify the presence of the virus in patient samples. In addition to its diagnostic applications, the HBsAg antibody has also been studied for its potential therapeutic uses. It has been shown to have an inhibitory effect on adiponectin, a hormone involved in regulating glucose metabolism and fatty acid oxidation. Furthermore, studies have demonstrated that this antibody can modulate the activity of activated androgen receptors, which play a role in various physiological processes. Moreover, the HBsAg antibody has been explored as a potential medicament for autoimmune disorders. Autoantibodies, which are antibodies produced by the immune system against self-antigens, can contribute to the development of</p>

<p>The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug that falls under the class of rifamycins. It is highly effective in treating tuberculosis infections, thanks to its bactericidal activity against the disease-causing bacteria. This drug works by binding to DNA-dependent RNA polymerase, thereby inhibiting transcription and replication. Its efficacy has been demonstrated through extensive research using advanced techniques like the patch-clamp technique on human erythrocytes. In addition to its direct action on Mycobacterium tuberculosis strains, this drug undergoes various metabolic transformations within the body. These include hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. With its unique mechanism of action and targeted effects on tuberculosis bacteria, 6-Fluoro-3-indoxyl-beta-D-g</p>

<p>NPTII antibody was raised in rabbit using purified neomycin phosphotransferase II as the immunogen.</p>

<p>The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug that falls under the class of rifamycins. It is specifically designed to combat tuberculosis infections by targeting the active compounds responsible for bactericidal activity. By binding to DNA-dependent RNA polymerase, this drug effectively inhibits bacterial growth, preventing transcription and replication. Additionally, it has been proven to exhibit high efficacy against Mycobacterium tuberculosis strains. The metabolism of this drug involves various transformations, including hydrolysis, oxidation, reduction, and conjugation. With its exceptional properties and targeted approach, the 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an invaluable weapon in the fight against tuberculosis.</p>

<p>Mouse IgG2b heavy chain antibody was raised in rat using murine IgG as the immunogen.</p>

<p>Hepatitis A virus antibody was raised in mouse using purified hepatitis A as the immunogen.</p>